The global Minimal Residual Disease (MRD) market size was USD 1,095.3 Million in 2021 and is expected to register a revenue CAGR of 16.04% during the forecast period, according to the latest analysis by Emergen Research. Rising R&D activities and increase in research funding from various cancer institutes are major factors projected to support market revenue growth between 2021 and 2030. For instance, Invitae Corporation, based in the U.S., started a research in February 2022 to collect actual data on tailored minimal residual disease diagnostics for distinct tumor types. Inivata also introduced RaDaR assay in April 2020 to identify and track residual disease and relapse in plasma samples of patients with prior cancer diagnoses. In addition, RaDaR assay is based on next-generation sequencing platform InVision liquid biopsy, developed by Inivata, which has built-in control and error checking for highly sensitive and precise variant detection. Moreover, to improve testing and detection outcomes, companies competing in the worldwide MRD testing market are concentrating more on disease-specific and tailored diagnostic kits, which is also expected to drive revenue growth of the market.

The Minimal Residual Disease Market report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.

Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1352

Competitive Terrain:

The global Minimal Residual Disease industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Adaptive Biotechnologies, ARUP Laboratories, Bio-Rad Laboratories, Inc., Cergentis B.V., F. Hoffmann-La Roche Ltd., ICON Plc, Invivoscribe, Inc., Laboratory Corporation of America Holdings, Mission Bio, Natera, Inc., NeoGenomics Laboratories, OPKO Health, Inc., and Sysmex Corporation

The research study examines historic data from 2018 and 2020 to draw forecasts until 2028. The timeline makes the report an invaluable resource for readers, investors, and stakeholders looking for key insights in readily accessible documents with the information presented in the form of tables, charts, and graphs.

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/minimal-residual-disease-market

Market Overview:

The report bifurcates the Minimal Residual Disease market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.

Segments Covered in this report are:

  • Indication Outlook (Revenue, USD Million; 2019–2030)

    • Leukemia
      1. Acute Lymphoblastic Leukemia (ALL)
      2. Chronic Lymphoblastic Leukemia (CLL)
      3. Acute Myeloid Leukemia (AML)
      4. Chronic Myeloid Leukemia (CML)
      5. Others
    • Lymphoma
      1. Non-Hodgkin’s Lymphoma (NHL)
      2. Marginal Zone Lymphoma
      3. Follicular Lymphoma
      4. Peripheral T-cell Lymphoma
      5. Mantle Cell Lymphoma
      6. Others
    • Multiple Myeloma (MM)
    • Solid Tumor
    • Others
  • Detection Outlook (Revenue, USD Million; 2019–2030)

    • Next-Generation Sequencing (NGS)
    • Flow Cytometry
    • Polymerase Chain Reaction (PCR)
    • Fluorescence In-Situ Hybridization (FISH)
    • Others
  • Treatment Methods Outlook (Revenue, USD Million; 2019–2030)

    • Chemotherapy
    • Stem Cell Transplant
    • CAR-T Cell Therapy
    • Others

The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market. 

Regional Analysis Covers:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Points Covered in This Section:

  • Regional contribution
  • Estimated revenue generation
  • Vital data and information about the consumption rate in all the leading regional segments
  • An expected rise in market share
  • Forecast growth in the overall consumption rate

Key Objectives of the Report:

  • Analysis and estimation of the Minimal Residual Disease market size and share for the projected period of 2020-2027
  • Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
  • Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Minimal Residual Disease market
  • Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
  • Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-history/1352

Latest Published Reports by Emergen Research:

https://ishadeshpande.listal.com/

https://englishbaby.com/findfriends/gallery/detail/2427288

https://www.ted.com/profiles/40957915

https://www.myoats.com/users/Ishadeshpande/tab8-0

https://www.blogtalkradio.com/ishadeshpande15

https://bietduoc.ucoz.net/blog/idaas_market_key_vendors_trends_development_strategy_future_prospects_and_regional_forecast_by_2028/2023-01-12-53

https://www.mycast.io/stories/application-program-interface-management-market?added=true

http://diendan.lyhocdongphuong.org.vn/profile/61373-ishadeshpande/

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Compression Therapy Market | Smart Insulin Pens Market

Latest Report:  Medical Electrodes Market  Olfactory Neuroblastoma Market